Clifford Courville is a Respiratory physician. OpenAlex indexes 9 publications with 733 citations (h-index 6).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
2770 3rd Ave Ste 350
Lake Charles, LA 706010404
Telephone
337-494-2750Provider last certified this registry record 28 Apr 2022.
Industry payments
37 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- GlaxoSmithKline, LLC.Program year202533 payments
- Boehringer Ingelheim Pharmaceuticals, Inc.Program year20254 payments
- GENZYME CORPORATIONProgram year202513 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Respiratory
57.4%Corticosteroid32.1%Trelegy Ellipta52%Breo Ellipta25%Symbicort8%Breyna4%Fluticasone Propionate3%Arnuity Ellipta3%Breztri Aerosphere3%Budesonide-Formoterol Fumarate2%Part D<11 patientsbeta2-Adrenergic Agonist12.7%Albuterol Sulfate Hfa88%Ventolin Hfa13%Part D≥114 patients+ 7 more classes in this area
Anti-infectives
16.7%Macrolide Antimicrobial9.7%Azithromycin100%Part D≥81 patientsFluoroquinolone Antibacterial1.6%Levofloxacin100%Part D≥52 patients+ 7 more classes in this area
Metabolism & gastrointestinal
9.8%Corticosteroid4.8%Prednisone100%Part D≥103 patientsProton pump inhibitor4.7%Omeprazole46%Pantoprazole Sodium46%Esomeprazole Magnesium8%Part D<11 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Recovery of Acquired Cystic Fibrosis Transmembrane Conductance Regulator Dysfunction after Smoking Cessation
American Journal of Respiratory and Critical Care Medicine
2015 - Cigarette Smoke Induces Systemic Defects in Cystic Fibrosis Transmembrane Conductance Regulator Function
American Journal of Respiratory and Critical Care Medicine
2013 - Cystic Fibrosis Transmembrane Conductance Regulator Activation by Roflumilast Contributes to Therapeutic Benefit in Chronic Bronchitis
American Journal of Respiratory Cell and Molecular Biology
2013
Similar KOLs
Other experts from the same institution or the same specialty.
Tim Driscoll
The University of Sydney
Francesco Saverio Violante
IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola
Mark A. Rubin
University of Bern
Marc Humbert
Inserm
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”